Effect of dalcetrapib, a CETP modulator, on non-cholesterol sterol markers of cholesterol homeostasis in healthy subjects
Eric J. Niesor, Evelyne Chaput, Andreas Staempfli, Denise Blum, Michael Derks, David Kallend
Index: Atherosclerosis 219(2) , 761-7, (2011)
Full Text: HTML
Abstract
Objective Subjects with high HDL-C show elevated plasma markers of cholesterol absorption and reduced markers of cholesterol synthesis. We evaluated the effect of dalcetrapib, a cholesteryl ester transfer protein modulator, on markers of cholesterol homeostasis in healthy subjects.
Related Compounds
Related Articles:
2015-02-15
[Food Chem. 169 , 92-101, (2014)]
2008-01-01
[Bioorg. Med. Chem. Lett. 20 , 7372-5, (2010)]
2014-05-01
[Environ. Pollut. 188 , 71-80, (2014)]
2014-10-01
[Am. J. Clin. Nutr. 100(4) , 1085-94, (2014)]
2013-01-01
[J. Neurol. 260(1) , 268-74, (2013)]